• Contains Vildagliptin, an oral antidiabetic medication.
• Commonly prescribed for the management of Type 2 diabetes mellitus.
• Helps support healthy blood glucose levels when used alongside diet and exercise.
• Belongs to the DPP-4 (dipeptidyl peptidase-4) inhibitor class.
• Supports improved glycemic control without significant risk of hypoglycemia when used appropriately.
• Trusted formulation from Novartis, a globally recognized pharmaceutical company.
• Suitable for use as monotherapy or in combination with other antidiabetic medicines as prescribed.
• Convenient oral tablet for daily use.
• Manufactured under stringent quality and safety standards.
• Prescription-only medication (Rx).

Galvus 50 mg Tablet is a prescription medication widely used in the management of Type 2 diabetes mellitus. Formulated with vildagliptin, this medicine belongs to the class of dipeptidyl peptidase-4 (DPP-4) inhibitors, which help regulate blood sugar levels by enhancing the body’s natural mechanisms for glucose control. It is typically prescribed when lifestyle modifications such as diet and exercise alone are insufficient to maintain optimal glycemic levels.

Vildagliptin works by inhibiting the DPP-4 enzyme, which leads to increased levels of incretin hormones like GLP-1 (glucagon-like peptide-1). These hormones stimulate insulin release from the pancreas in response to elevated blood sugar levels while reducing glucagon secretion. This dual action helps maintain balanced glucose levels, particularly after meals, making Galvus 50 mg Tablet an effective option in diabetes care under medical supervision.

Type 2 diabetes is a chronic metabolic disorder characterized by insulin resistance and impaired insulin secretion. If left unmanaged, it can lead to serious complications such as cardiovascular disease, kidney disorders, nerve damage, and vision problems. Galvus 50 mg Tablet supports better glycemic control, thereby assisting in reducing the risk of diabetes-related complications when used as part of a comprehensive treatment plan.

Manufactured by Novartis, a renowned global pharmaceutical company, Galvus adheres to strict international quality standards. Its reliable formulation and proven clinical efficacy have made it a trusted choice among healthcare professionals worldwide. The tablet form ensures ease of administration and promotes patient adherence to long-term therapy.

Galvus 50 mg Tablet may be prescribed as a standalone treatment or in combination with other antidiabetic medications such as metformin, sulfonylureas, or insulin, depending on the patient's medical condition. The dosage is individualized based on factors such as age, blood glucose levels, and overall health status. Patients are advised to follow their doctor’s instructions carefully for optimal results.

This medication is generally well tolerated. However, mild side effects such as headache, dizziness, or nausea may occur in some individuals. Regular monitoring of blood glucose levels and routine medical check-ups are recommended during treatment. Patients should inform their healthcare provider about any pre-existing medical conditions or ongoing medications to avoid potential interactions.

Galvus 50 mg Tablet should be taken with or without food, preferably at the same time each day. Consistency in administration enhances therapeutic effectiveness and helps maintain stable blood sugar levels. It is important not to skip doses or discontinue the medication without consulting a healthcare professional.

Galvus 50 mg Tablet offers an effective and reliable approach to managing Type 2 diabetes. With its advanced DPP-4 inhibitor mechanism, global brand credibility, and patient-friendly formulation, it plays a significant role in modern diabetes management when used responsibly under medical supervision.

Active Ingredients:

Each tablet contains:

• Vildagliptin – 50 mg.

• Take this medicine exactly as prescribed by your doctor.
• Swallow the tablet whole with water.
• It can be taken with or without food.
• Take it at the same time each day for best results.
• Do not crush or chew the tablet.
• Do not discontinue without consulting your healthcare provider.

• Prescription-only medicine; use under medical supervision.
• Not recommended for Type 1 diabetes or diabetic ketoacidosis.
• Inform your doctor if you have liver, kidney, or heart conditions.
• Regular monitoring of blood sugar and liver function is advised.
• Avoid alcohol unless approved by your doctor.
• Consult your doctor if pregnant or breastfeeding.
• Inform your healthcare provider about other medications being taken.
• Store in a cool, dry place away from direct sunlight.
• Keep out of reach of children.
• Read the label carefully before use.

Generic Name: Vildagliptin.

Dosage Form: Tablet.

Prescription Required: Yes (Rx).

Storage: Store below 30°C in a dry place.

Q1. What is Galvus 50 mg Tablet used for?
It is prescribed for the management of Type 2 diabetes mellitus to help control blood sugar levels.

Q2. What is the active ingredient in Galvus 50 mg?
The active ingredient is vildagliptin.

Q3. How does Galvus work?
It inhibits the DPP-4 enzyme, enhancing incretin hormones that regulate insulin and glucagon levels.

Q4. Is Galvus a prescription medicine?
Yes, it should be taken only under a doctor’s supervision.

Q5. Can Galvus be taken with other diabetes medications?
Yes, it may be prescribed in combination with other antidiabetic drugs as directed by a healthcare professional.

Q6. When should I take Galvus 50 mg Tablet?
It can be taken with or without food, preferably at the same time each day.

Q7. Does Galvus cause hypoglycemia?
It has a low risk when taken alone but may cause hypoglycemia when combined with other diabetes medications.

Q8. Is Galvus suitable for Type 1 diabetes?
No, it is not indicated for Type 1 diabetes or diabetic ketoacidosis.

Q9. What should I do if I miss a dose?
Take it as soon as you remember. Skip it if it is close to the next dose—do not double the dose.

Q10. How should Galvus be stored?
Store in a cool, dry place away from heat, light, and moisture.

Name: Novartis India Ltd.

Address: Sandoz House, Shiv Sagar Estate, Worli Mumbai -400 018, India.